Targeting the undruggables—the power of protein degraders-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Targeting the undruggables—the power of protein degraders

Published:2024-06 Issue:11 Volume:69 Page:1776-1797
ISSN:2095-9273
Container-title:Science Bulletin
language:en
Short-container-title:Science Bulletin

Author:

Zhang Chao,Liu Yongbo,Li Guangchen,Yang Zhouli,Han Chi,Sun Xiuyun,Sheng Chunquan,Ding Ke,Rao Yu

Funder

National Natural Science Foundation of China

National Key Research and Development Program of China

Publisher

Elsevier BV

Reference122 articles.

1. Drugging the ‘undruggable’ cancer targets;Dang;Nat Rev Cancer,2017

2. Recent advances in targeting the “undruggable” proteins: From drug discovery to clinical trials;Xie;Signal Transduct Target Ther,2023

3. Strategies for targeting undruggable targets;Zhang;Expert Opin Drug Discov,2022

4. RNA-targeting therapy: A promising approach to reach non-druggable targets;Zaafar;Biomed Pharmacol J,2021

5. Current strategies and progress for targeting the “undruggable” transcription factors;Zhuang;Acta Pharmacol Sin,2022

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Design, synthesis, and biological evaluation of RSL3-based GPX4 degraders with hydrophobic tags;European Journal of Medicinal Chemistry;2024-11

2. Posttranslational modifications of E2F family members in the physiological state and in cancer: Roles, mechanisms and therapeutic targets;Biomedicine & Pharmacotherapy;2024-09

3. Small molecular inhibitors and degraders targeting STAT3 for cancer therapy: An updated review (from 2022 to 2024);Chinese Chemical Letters;2024-09

4. Targeted degradation of membrane and extracellular proteins with LYTACs;Acta Pharmacologica Sinica;2024-08-05

5. Targeted Protein Degradation (TPD) for Immunotherapy: Understanding Proteolysis Targeting Chimera-Driven Ubiquitin-Proteasome Interactions;Bioconjugate Chemistry;2024-07-11

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3